Data as of Apr 16
| +1.01 / +1.62%|
The 31 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 62.00, with a high estimate of 77.00 and a low estimate of 44.86. The median estimate represents a -2.41% decrease from the last price of 63.53.
The current consensus among 32 polled investment analysts is to Hold stock in AstraZeneca PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.